(Published in Part II, Section 3, Sub Section (ii) of the Gazette of India
Extraordinary, dated the 20th july, 2000)

Government of India
Ministry of Chemicals and Fertilizers
National Pharmaceuticals Pricing Authority

New Delhi, the 20^th July, 2000

S.O. 681(E) – In exercise of the powers, conferred by sub-paragraph (1) and (2) of paragraph 9 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637 (E) dated the 4^th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof :

Table

Note :

1. The above ceiling prices mentioned in the column no. 5 are applicable to all manufacturers/formulators who are using either imported Erythromycin Estolate or Erythromycin Estolate manufactured from imported TIOC (Erythromycin Thiocynate).

2 (i) The ceiling prices of Erythromycin Estolate formulation notified vide S.O. No. 195(E) dated 11^th March, 1998 shall be applicable to only those formulators/manufacturers who are using Erythromycin Estolate manufactured from TIOC produced from basic stage of fermentation in the country.

2 (ii) Such manufacturers/formulators are required to submit quarterly production return by 10^th of January, April, July and October of its preceeding quarter to Govt./NPPA giving details of in-house production of bulk drug, purchase of bulk drug, showing separately Erythromycin Estolate made out of indigenous and imported TIOC and consumption thereof in production of formulations as per proforma which has been prescribed.

PN/38/2000/F

F. No. 8(27)/2000/D.P./NPPA-Div.II

(L. M. Kaushal)
Deputy Director
National Pharmaceutical
Pricing Authority